LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Kodu・Aktsiate loetelu・HealthEquity Inc

HealthEquity Inc

Suletud

SektorTervishoid

93.64 1.06

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

92.88

Max

93.69

Põhinäitajad
By Trading Economics
Sissetulek	5.9M 60M
Müük	-5M 326M
P/E Sektori keskmine	57.461 77.256
Kasumimarginaal	18.369
Töötajad	3,105
EBITDA	6.9M 131M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+31.47% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	3. dets 2025

Turustatistika
By TradingEconomics
Turukapital	444M 8.2B
Eelmine avamishind	92.58
Eelmine sulgemishind	93.64

Uudiste sentiment

By Acuity

14%

86%

15 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

85.83 / 92.82 Toetus ja vastupanu

HealthEquity Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. nov 2025, 21:36 UTC

Tulu

Australia's ANZ Bank Posts 10% Drop in Annual Profit -- Update

9. nov 2025, 21:22 UTC

Tulu

Australia's ANZ Bank Posts 10% Drop in Annual Profit

10. nov 2025, 00:00 UTC

Market Talk

India Inflation Poised to Hit New Low -- Market Talk

9. nov 2025, 23:47 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

9. nov 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Signs of U.S. Economic Weakness -- Market Talk

9. nov 2025, 21:05 UTC

Tulu

ANZ FY Total Operating Expenses A$12.88B Vs. A$11.465B Pro Forma>ANZ.AU

9. nov 2025, 21:04 UTC

Tulu

ANZ FY Operating Expenses A$11.85B Ex-Significant Items>ANZ.AU

9. nov 2025, 21:03 UTC

Tulu

ANZ 2H Net Interest Margin 1.54% Vs. 1.56% in 1H>ANZ.AU

9. nov 2025, 20:49 UTC

Tulu

ANZ FY Australia Retail Deposits Up 6% on Year>ANZ.AU

9. nov 2025, 20:49 UTC

Tulu

ANZ FY Australia Home Loan Lending Up 5% on Year>ANZ.AU

9. nov 2025, 20:45 UTC

Tulu

ANZ FY Average Customer Deposits A$760.8B Vs. A$669.4B>ANZ.AU

9. nov 2025, 20:45 UTC

Tulu

ANZ FY Average Gross Loans & Advances A$833.6B Vs. A$733.8B>ANZ.AU

9. nov 2025, 20:42 UTC

Tulu

ANZ FY Results Include Full-Year Benefit of Suncorp Bank Acquisition>ANZ.AU

9. nov 2025, 20:42 UTC

Tulu

ANZ FY Net Interest Margin 1.55% Vs. 1.57%>ANZ.AU

9. nov 2025, 20:41 UTC

Tulu

ANZ FY Common Equity Tier 1 Ratio 12.0% Vs. 12.2%>ANZ.AU

9. nov 2025, 20:41 UTC

Tulu

ANZ FY Net Profit Includes A$1.11B of Notable Items>ANZ.AU

9. nov 2025, 20:39 UTC

Tulu

ANZ FY Credit Impairment Charge A$441M Vs. A$406M>ANZ.AU

9. nov 2025, 20:39 UTC

Tulu

ANZ FY Rev A$22.19B Vs. A$20.55B >ANZ.AU

9. nov 2025, 20:38 UTC

Tulu

ANZ Keeps Dividend at A$0.83 >ANZ.AU

9. nov 2025, 20:38 UTC

Tulu

ANZ FY Cash Profit A$5.79B Vs. A$6.725B>ANZ.AU

9. nov 2025, 20:38 UTC

Tulu

ANZ FY Net A$5.89B Vs. Net A$6.535B >ANZ.AU

8. nov 2025, 13:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. nov 2025, 03:50 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. nov 2025, 03:41 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. nov 2025, 03:07 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. nov 2025, 22:36 UTC

Tulu

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7. nov 2025, 22:22 UTC

Tulu

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Rev $2.95B >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Net $210M >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q EPS $9.89 >CSU.T

Võrdlus sarnastega

Hinnamuutus

HealthEquity Inc Prognoos

Hinnasiht

By TipRanks

31.47% tõus

12 kuu keskmine prognoos

Keskmine 123.2 USD 31.47%

Kõrge 134 USD

Madal 110 USD

Põhineb 10 Wall Streeti analüütiku instrumendi HealthEquity Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi HealthEquity Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

85.83 / 92.82Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

15 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest HealthEquity Inc

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.